Spero Therapeutics, Inc. (a Delaware corporation) 4,785,000 Shares of Common Stock 3,215,000 Shares of Series D Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2020 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
